2026-2034年全球尿道感染治療市場規模、佔有率、趨勢及成長分析報告

預計到 2034 年，尿道感染治療市場規模將達到 1,086,610,000 美元，高於 2025 年的 69,924 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 5.02%。

受細菌感染疾病增加和公眾健康意識提高的推動，全球尿道感染（UTI）治療市場正穩步成長。尿道感染是全球最常見的感染疾病之一，尤其影響女性和老年人。醫療服務和診斷設施的普及進一步增強了對治療的需求。藥物研發的拓展也進一步推動了市場成長。

成長要素包括抗生素處方量的增加和先進治療方法的研發。人們對早期診斷和預防醫學的意識提升，也促進了治療率的提升。發展中地區醫療基礎設施的擴建也支持了市場成長。此外，對替代療法和標靶治療的研究也正在加速推進。

由於醫藥創新不斷推進，前景依然樂觀。新型抗菌藥物和聯合治療的研發有望應對抗生素抗藥性挑戰。遠端醫療和診斷工具的改進或將提升患者獲得治療的機會。隨著全球醫療保健需求的成長，市場預計將穩步發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球尿道感染治療市場：依檢測套組

• 市場分析、洞察與預測
• 家用檢測套組
• 實驗室檢測套組

第5章 全球尿道感染治療市場：依感染疾病類型分類

• 市場分析、洞察與預測
• 尿道炎
• 膀胱炎
• 腎盂腎炎

第6章：全球尿道感染治療市場：依檢測類型分類

• 市場分析、洞察與預測
• 尿液檢查
• 尿液培養試驗
• 敏感性測試

第7章 全球尿道感染治療市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 其他

第8章 全球尿道感染治療市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Stryker Corporation
  • ACON Laboratories Inc
  • LabCorp（Laboratory Corporation Of America Holdings）
  • Abbott Laboratories
  • Cardinal Health Inc
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc
  • Roche AG

The Urinary Tract Infection Treatment Market size is expected to reach USD 1086.61 Million in 2034 from USD 699.24 Million (2025) growing at a CAGR of 5.02% during 2026-2034.

The Global Urinary Tract Infection Treatment market has grown steadily due to increasing prevalence of bacterial infections and rising healthcare awareness. UTIs are among the most common infections globally, particularly affecting women and elderly populations. Growing access to healthcare services and diagnostic facilities has strengthened treatment demand. Expanding pharmaceutical research further supports market development.

Growth drivers include rising antibiotic prescriptions and development of advanced therapeutic options. Increased awareness about early diagnosis and preventive care contributes to higher treatment rates. Healthcare infrastructure expansion in developing regions also supports market growth. Additionally, research into alternative and targeted therapies is gaining momentum.

Future prospects remain promising as pharmaceutical innovation continues. Development of new antimicrobial agents and combination therapies will address antibiotic resistance challenges. Telemedicine and improved diagnostic tools may enhance treatment accessibility. The market is expected to grow steadily with rising global healthcare demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Kit

• Home Test Kits
• Laboratory Test Kits

By Infection Type

• Urethritis
• Cystitis
• Pyelonephritis

By Test Type

• Urinalysis
• Urine Cultures
• Susceptibility Testing

By End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

COMPANIES PROFILED

• Stryker Corporation, ACON Laboratories Inc, LabCorpLaboratory Corporation of America Holdings, Abbott Laboratories, Cardinal Health Inc, BioRad Laboratories, Danaher Corporation, Sysmex Corporation, Thermo Fisher Scientific Inc, Roche AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL URINARY TRACT INFECTION TREATMENT MARKET: BY TEST KIT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Kit
• 4.2. Home Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Laboratory Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL URINARY TRACT INFECTION TREATMENT MARKET: BY INFECTION TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Infection Type
• 5.2. Urethritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cystitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Pyelonephritis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL URINARY TRACT INFECTION TREATMENT MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Urinalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Urine Cultures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Susceptibility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL URINARY TRACT INFECTION TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL URINARY TRACT INFECTION TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Test Kit
  • 8.2.2 By Infection Type
  • 8.2.3 By Test Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Test Kit
  • 8.3.2 By Infection Type
  • 8.3.3 By Test Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Test Kit
  • 8.4.2 By Infection Type
  • 8.4.3 By Test Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Test Kit
  • 8.5.2 By Infection Type
  • 8.5.3 By Test Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Test Kit
  • 8.6.2 By Infection Type
  • 8.6.3 By Test Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL URINARY TRACT INFECTION TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Stryker Corporation
  • 10.2.2 ACON Laboratories Inc
  • 10.2.3 LabCorp(Laboratory Corporation Of America Holdings)
  • 10.2.4 Abbott Laboratories
  • 10.2.5 Cardinal Health Inc
  • 10.2.6 Bio-Rad Laboratories
  • 10.2.7 Danaher Corporation
  • 10.2.8 Sysmex Corporation
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 Roche AG